{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:20:12Z","timestamp":1769109612315,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2692,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Survival benefit of percutaneous mitral valve repair with the MitraClip over conservative treatment of functional mitral regurgitation (MR) remains unclear. The purpose of this meta-analysis is to compare survival outcomes of MitraClip with those of medical therapy in patients with functional MR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A comprehensive literature search of PubMed, MEDLINE, and Google Scholar was conducted including studies evaluating MitraClip vs. medical therapy with multivariate adjustment and with &amp;gt;80% of patients with functional MR. Death from any cause was the primary endpoint, while freedom from readmission was the secondary one, evaluated with random effects. These analyses were performed at study level and at patient level including only functional MR when available, evaluating the effect of MitraClip in different subgroups according to age, ischaemic aetiology, presence of implantable cardioverter defibrillator\/cardiac resynchronization therapy, and left ventricular ejection fraction and volumes. We identified six eligible observational studies including 2121 participants who were treated with MitraClip (n = 833) or conservative therapy (n = 1288). Clinical follow-up was documented at a median of 400 days. At study-level analysis, MitraClip, when compared with medical therapy (P = 0.005), was associated with significant reduction of death (P = 0.002) and of readmission due to cardiac disease. At patient-level analysis, including 344 patients, MitraClip confirmed robust survival benefit over medical therapy for all patients with functional MR and among the most important subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared with conservative treatment, MitraClip is associated with a significant survival benefit. Importantly, this superiority is particularly pronounced among patients with functional MR and across all the main subgroups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12339","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:09:29Z","timestamp":1536278969000},"page":"1150-1158","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Meta-Analysis of MitraClip Combined with Medical Therapy vs. Medical Therapy Alone for Treatment of Mitral Regurgitation in Heart Failure Patients"],"prefix":"10.1093","volume":"5","author":[{"given":"Cristina","family":"Giannini","sequence":"first","affiliation":[{"name":"Azienda Ospedaliero-Universitaria Pisana , Pisa ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"D'ascenzo","sequence":"additional","affiliation":[{"name":"Universit\u00e0 di Torino-Citt\u00e0 della Salute e della Scienza , Turin ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Fiorelli","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero-Universitaria Pisana , Pisa ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Spontoni","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero-Universitaria Pisana , Pisa ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Swaans","sequence":"additional","affiliation":[{"name":"St. Antonious Hospital , Nieuwegein ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Velazquez","sequence":"additional","affiliation":[{"name":"Duke University Medical Center , Durham, NC ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Armeni","sequence":"additional","affiliation":[{"name":"Bocconi University , Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Adamo","sequence":"additional","affiliation":[{"name":"Spedali Civili Brescia , Brescia ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"De Carlo","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero-Universitaria Pisana , Pisa ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Sonia","family":"Petronio","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero-Universitaria Pisana , Pisa ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"2026012115110800000_ehf212339-bib-0001","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.CIR.103.13.1759","article-title":"Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment","volume":"103","author":"Grigioni","year":"2001","journal-title":"Circulation"},{"key":"2026012115110800000_ehf212339-bib-0002","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(09)60692-9","article-title":"Mitral regurgitation","volume":"373","author":"Enriquez-Sarano","year":"2009","journal-title":"Lancet"},{"key":"2026012115110800000_ehf212339-bib-0003","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012115110800000_ehf212339-bib-0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jacc.2009.08.059","article-title":"Mitral valve surgery in advanced heart failure","volume":"55","author":"Di Salvo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0005","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"key":"2026012115110800000_ehf212339-bib-0006","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"2026012115110800000_ehf212339-bib-0007","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurjhf\/hfr029","article-title":"MitraClip\u00ae therapy in patients with end-stage systolic heart failure","volume":"13","author":"Franzen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026012115110800000_ehf212339-bib-0008","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jacc.2011.08.067","article-title":"Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study","volume":"59","author":"Whitlow","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2013.12.062","article-title":"Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study","volume":"64","author":"Glower","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjcard.2015.04.025","article-title":"Meta-analysis of the usefulness of MitraClip in patients with functional mitral regurgitation","volume":"116","author":"D'ascenzo","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0011","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/ejhf.169","article-title":"Clinical outcome of critically ill, not fully recompensated, patients undergoing MitraClip therapy","volume":"16","author":"Rudolph","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012115110800000_ehf212339-bib-0012","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jcin.2014.01.171","article-title":"Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients","volume":"7","author":"Swaans","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2026012115110800000_ehf212339-bib-0013","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ahj.2015.08.004","article-title":"The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison","volume":"170","author":"Velazquez","year":"2015","journal-title":"Am Heart J"},{"key":"2026012115110800000_ehf212339-bib-0014","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.amjcard.2015.10.044","article-title":"Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation","volume":"117","author":"Giannini","year":"2016","journal-title":"Am J Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijcard.2016.01.212","article-title":"Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation","volume":"209","author":"Armeni","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0016","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13696998.2016.1227828","article-title":"Clinical outcomes and economic impact of transcatheter mitral leaflet repair in heart failure patients","volume":"20","author":"Asgar","year":"2017","journal-title":"J Med Econ"},{"key":"2026012115110800000_ehf212339-bib-0017","volume-title":"MitraClip versus optimal medical therapy for patients with advanced heart failure and severe mitral regurgitation: a propensity-score matched analysis","author":"Adamo","year":"2017"},{"key":"2026012115110800000_ehf212339-bib-0018","volume-title":"The Cochrane Collaboration","author":"S HJG","year":"2009"},{"key":"2026012115110800000_ehf212339-bib-0019","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"2026012115110800000_ehf212339-bib-0020","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2026012115110800000_ehf212339-bib-0021","first-page":"e521","article-title":"2014 AHA\/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Nishimura","year":"2014","journal-title":"Circulation"},{"key":"2026012115110800000_ehf212339-bib-0022","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012115110800000_ehf212339-bib-0023","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ejcts\/ezs294","article-title":"MitraClip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience","volume":"42","author":"Taramasso","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012115110800000_ehf212339-bib-0024","first-page":"683","article-title":"A meta-analysis of MitraClip system versus surgery for treatment of severe mitral regurgitation","volume":"2","author":"Wan","year":"2013","journal-title":"Ann Cardiothorac Surg"},{"key":"2026012115110800000_ehf212339-bib-0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ehjci\/jet141","article-title":"Integrated reverse left and right ventricular remodelling after MitraClip implantation in functional mitral regurgitation: an echocardiographic study","volume":"15","author":"Giannini","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012115110800000_ehf212339-bib-0026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ahj.2015.04.010","article-title":"Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair","volume":"170","author":"Capodanno","year":"2015","journal-title":"Am Heart J"},{"key":"2026012115110800000_ehf212339-bib-0027","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amjcard.2016.10.049","article-title":"Immediate and 12-month outcomes of ischemic versus nonischemic functional mitral regurgitation in patients treated with MitraClip (from the 2011 to 2012 Pilot Sentinel Registry of Percutaneous Edge-To-Edge Mitral Valve Repair of the European Society of Cardiology)","volume":"119","author":"Pighi","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0028","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/eurjhf\/hfs214","article-title":"Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure","volume":"15","author":"Neuss","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012115110800000_ehf212339-bib-0029","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijcard.2016.08.189","article-title":"Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy","volume":"223","author":"Giannini","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012115110800000_ehf212339-bib-0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jacc.2013.10.021","article-title":"Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair","volume":"64","author":"Lim","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12339","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/6\/1150\/66137347\/eschf_5_6_1150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/6\/1150\/66137347\/eschf_5_6_1150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:14:37Z","timestamp":1769026477000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/5\/6\/1150\/8403702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,9,6]]},"published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12339","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,9,6]]},"assertion":[{"value":"2018-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}